Hematócrito baixo compromete a remoção de CO2 da mucosa gástrica na hemodiluição normovolêmica intensa experimental by Perin, Daniel et al.
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LOW HEMATOCRIT IMPAIRS GASTRIC MUCOSAL
CO2 REMOVAL DURING EXPERIMENTAL SEVERE
NORMOVOLEMIC HEMODILUTION
Daniel Perin, Ruy J. Cruz Jr, Eliezer Silva, and Luiz Francisco Poli-de-Figueiredo
Perin D, Cruz Jr. RJ, Silva E, Rocha-e-Silva M, Poli-de-Figueiredo LF. Low hematocrit impairs gastric mucosal co2
removal during experimental severe normovolemic hemodilution. CLINICS. 2006(5):445-52.
OBJECTIVE: The net effects of acute normovolemic hemodilution with different hemoglobin levels on splanchnic perfusion
have not been elucidated. The hypothesis that during moderate and severe normovolemic hemodilution, systemic and splanchnic
hemodynamic parameters, oxygen-derived variables, and biochemical markers of anaerobic metabolism do not reflect the adequacy
of gastric mucosa, was tested in this study.
METHODS: Twenty one anesthetized mongrel dogs (16 ± 1 kg) were randomized to controls (CT, n = 7, no hemodilution),
moderate hemodilution (hematocrit 2 5% ± 3%, n = 7) or severe hemodilution (severe hemodilution, hematocrit 15% ± 3%, n = 7),
through an isovolemic exchange of whole blood and 6% hydroxyethyl starch, at a 20 mL/min rate, to the target hematocrit. The
animals were followed for 120 min after hemodilution. Cardiac output (CO, L/min), portal vein blood flow (PVF, mL/min), portal
vein-arterial and gastric mucosa-arterial CO2 gradients (PV-artCO2 and PCO2 gap, mm Hg, respectively) were measured throughout
the experiment.
RESULTS: Exchange blood volumes were 33.9 ± 3.3 and 61.5 ± 5.8 mL/kg for moderate hemodilution and severe hemodilution,
respectively. Arterial pressure and systemic and regional lactate levels remained stable in all groups. There were initial increases
in cardiac output and portal vein blood flow in both moderate hemodilution and severe hemodilution; systemic and regional
oxygen consumption remained stable largely due to increases in oxygen extraction rate. There was a significant increase in the
PCO2-gap value only in severe hemodilution animals.
CONCLUSION: Global and regional hemodynamic stability were maintained after moderate and severe hemodilution. However,
a very low hematocrit induced gastric mucosal acidosis, suggesting that gastric mucosal CO2 monitoring may be useful during
major surgery or following trauma.
KEYWORDS: Gas tonometry. Hemodilution. Oxygen metabolism. Regional hemodynamics. Splanchnic perfusion.
INTRODUCTION
The increasing frequency of complex surgical proce-
dures with extensive blood loss, the high costs of transfu-
sion therapy, the shortages in blood banks and the risk of
transmission of diseases such as acquired immune defi-
ciency syndrome and hepatitis have increased interest for
the intraoperative use of acute normovolemic hemodilution
(ANH).1,2
Acute normovolemic hemodilution refers to blood re-
moval and simultaneous replacement with acellular fluids
immediately before surgical procedures. Hemodilution
could be classified according to the target hematocrit (Ht)
as mild (hematocrit ≥ 30%), moderate (30 < hematocrit
≥ 20%), or severe (hematocrit < 20%).3 A decrease in
hemoglobin levels after ANH results in reduction of arte-
rial oxygen content and a compensatory increase in car-
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diac output. However, a decrease in tissue oxygen deliv-
ery, particularly to splanchnic organs, is a possible unde-
sirable by-product.
Hypoperfusion of the splanchnic bed has been impli-
cated as the trigger of systemic inflammatory response due
to bacterial or toxin translocation from the gut lumen to
blood stream, and this phenomenon has been associated
with the development of postoperative multiple organ dys-
function and to a worsened outcome.4 The net effects of
ANH with different hemoglobin levels on splanchnic
perfusion have not been elucidated. We tested the hypoth-
esis that during moderate and severe normovolemic
hemodilution, systemic and splanchnic hemodynamic pa-
rameters, oxygen-derived variables, and biochemical mark-
ers of anaerobic metabolism do not necessarily reflect the
adequacy of gastric mucosal perfusion, which may be im-
paired.
MATERIALS AND METHODS
The experimental protocol was approved by the Ethi-
cal Review Board of the Institution with adherence to the
“Principles of Laboratory Animal Care” formulated by the
National Society for Medical Research and to the “Guide
for the Care and Use of Animals” by the National Insti-
tutes of Health.
Animal preparation
The present study was performed using 21 male mon-
grel dogs, weighing 16.7 ± 0.7 kg. The animals were fasted
for 12 hours before the study, with free access to water.
Animals with a hematocrit below 30% were excluded.
Anesthesia was induced with an intravenous injection of
sodium pentobarbital, 25 mg/kg. After endotracheal intu-
bation, the animals were mechanically ventilated. The ven-
tilator was adjusted to achieve an initial arterial PCO2 be-
tween 35 and 45 mm Hg, with a 1.0 inspired oxygen frac-
tion throughout the experiment. Anesthesia was maintained
with intravenous injections of fentanyl (0.005 mg/kg/h) and
vecuronium bromide (0.15 mg/kg/h).
The right common femoral vein was catheterized for
measurement of inferior vena cava pressure, for infusion
of Ringer’s solution (4 mL/kg/h) during the experiment, and
for volume replacement during hemodilution. A
polyethylene cannula was inserted into the right common
femoral artery for blood removal. The left common femo-
ral artery was catheterized to measure the mean arterial
pressure (MAP) and to collect samples for blood gas, pH,
bicarbonate, base deficit, hematocrit, and hemoglobin
analysis.
A 7.5 Fr flow-directed thermodilution fiberoptic pulmo-
nary artery catheter with thermal filament (CCOmbo
744H7.5F, Edwards Swan-Ganz, Edwards Life and Sci-
ences, Irvine, CA, USA) was introduced through the right
external jugular vein and its tip placed into the pulmonary
artery, guided by pressure monitoring and wave tracings.
This catheter was connected to a cardiac computer (Vigi-
lance, Edwards Life and Sciences) to measure mean pul-
monary arterial pressure and cardiac output and to collect
mixed venous samples for blood gas analysis. All pressure-
measuring catheters were connected to pressure transduc-
ers (Transpac Disposable Transducer, Abbott, Chicago, IL,
USA) and then to a Biopac Data Acquisition System
(Model MP100, Biopac Systems, Goleta, CA, USA) for
continuous recording of systemic and pulmonary artery
pressures.
Through a median laparotomy, the spleen was removed,
and a polyethylene catheter was placed into the portal vein,
through the splenic vein, to draw blood samples and moni-
tor portal vein pressure. A transit time ultrasonic flowprobe
(Transonic System Inc., Ithaca, NY, USA) was positioned
around the portal vein and connected to a flowmeter (T206
Transonic Volume Flowmeter, Transonic Systems, Inc,
Ithaca, NY, USA).
An orogastric tube was inserted into the stomach, and
gastric lavage was performed using warm isotonic saline
solution, until a clear fluid solution was obtained. A 16F
TRIP® tonometry catheter was then introduced orally and
manually placed along the greater gastric curvature. This
catheter was connected to a gas capnometer (Tonocap,
model TC-200, Tonometrics, Datex-Egstrom, Finland) for
gastric PCO2 measurement.
Hemodilution was produced progressively by removing
blood from the right common femoral artery at a rate of
20 mL/min while replacing it with 6% hydroxyethyl starch
(Plasmasteril, Fresenius Laboratórios Ltda., São Paulo, Bra-
zil) pumped into the left common femoral vein at the same
rate.
The total volume removed (TVR) necessary to obtain
a given hematocrit (dHct) was calculated using the initial
hematocrit (iHct) according to the following formula:
TVR (mL) = [70 mL x weight (kg)] x [(iHct-dHct)/
(iHctc+dHct/2)]
A microhematocrit sample was obtained every 5 min-
utes during the hemodilution to check exactly whether the
desired hematócrito was attained.
Experimental design
After the completion of surgical preparation, the ani-
mals were allowed to stabilize for 30 minutes. Baseline
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measurements were obtained, and the animals were ran-
domly assigned to 3 experimental groups: CT (control, n
= 7), MHD (moderate normovolemic hemodilution, n = 7,
hematocrit = 25% ± 3%) and SHD (severe normovolemic
hemodilution, n = 7, hematocrit = 15% ± 3%).
The animals were followed for 120 minutes after
hemodilution and were euthanized by anesthesia overdose
and hypertonic potassium chloride solution injection.
Measured variables
Mean systemic and pulmonary arterial pressures, heart
rate, and mesenteric artery blood flow were continuously
recorded. Cardiac output was determined using 3-mL bo-
lus injections of isotonic saline at 20oC. Each determina-
tion was the arithmetic mean of 3 consecutive measure-
ments when their differences did not exceed 10%.
Arterial, portal, and mixed venous base deficit, pH,
PCO2, oxygen tension, oxygen saturation, hemoglobin,
hematocrit, and bicarbonate levels, were obtained at base-
line (BL), immediately after the end of hemodilution
(HD0), and 30, 60, 90, and 120 minutes after hemodilution.
All arterial, venous, and portal blood samples were
analyzed by a Stat Profile Ultra Analyzer (Nova Biomedi-
cal, Waltham, MA, USA).
Systemic and pulmonary vascular resistance (SVR and
PVR), oxygen delivery and consumption (DO2 and VO2),
and the systemic and splanchnic oxygen extraction ratios
(O2ERsyst and O2ERsplanc) were calculated using stand-
ard formulae.
Gastric mucosal PCO2 (PrCO2) was evaluated every 10
minutes. PCO2 gap was calculated as the difference be-
tween gastric mucosal and arterial PCO2.
Statistical methodology
Results are expressed as mean ± standard error of mean
(SEM). Statistical analysis was performed using a Statis-
tic Package for Social Sciences for Windows software (ver-
sion 6.0, SPSS Inc., Chicago, IL, USA).
Differences between groups were analyzed using re-
peated measures analysis of variance and post hoc Tukey’s
test. Statistical significance was considered for P values less
than 0.05.
RESULTS
Baseline measurements were similar between groups.
Both moderate and severe acute normovolemic
hemodilution promoted a sustained and significant reduc-
tion in hematocrit levels, as planned (Figure 1). Mean ar-
terial pressure (Figure 2A), central venous, and pulmonary
wedge pressures (not shown) showed no significant changes
throughout the experimental protocol in all groups.
There was a significant increase in cardiac output after
hemodilution in both MHD and SHD up to time point
HD30; thereafter, this difference was no longer significant
(Figure 2B).
Hemodilution promoted a transient significant increase
in portal vein blood flow in comparison to baseline values
in the MHD and SHD groups at HD0, HD30, and HD60.
However, there was no significant difference between
groups when considered for the entire experimental time.
(Figure 3A).
Figure 2 - (A) Mean arterial pressure during the experiment in the control
(CT), moderate hemodilution (MHD), and severe hemodilution (SHD)
groups. No significant changes between and within groups were observed.
(B) Cardiac output during the experiment in the control (CT), moderate
hemodilution (MHD) and severe hemodilution (SHD) groups. (a) MHD vs
CT, P < 0.01; (b) SHD vs CT, P < 0.01.
Figure 1- Arterial hematocrit during the experiment in the control (CT),
moderate hemodilution (MHD), and severe hemodilution (SHD) groups.
(a) MHD vs CT, P < 0.05; (b) SHD vs CT, P < 0.05; (c) MHD vs SHD, P <
0.05.
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cant changes during the entire experiment. Hemodilution
promoted a sustained decrease in systemic and regional
oxygen delivery, which was significantly greater in the SHD
than in the MHD group. Systemic and regional oxygen con-
sumption remained stable through increases in oxygen ex-
traction rate. Additionally, systemic and regional lactate
levels did not rise in the 3 groups.
There was no significant increase in the PCO2 gap in
the CT and MHD groups (P = 0.207). In contrast, there
was a significant increase in the PCO2 gap in the SHD
group (Figure 3B).
DISCUSSION
The main finding of this study, which is part of a gen-
eral program of experimental analysis of fluid replace-
ment5,6 was that both moderate and severe hemodilution are
associated with regional and systemic hemodynamic sta-
bility. However, severe hemodilution, to a hematocrit of
15%, induces moderate gastric mucosal acidosis and an in-
creased PCO2 gap. These findings may become relevant in
the presence of a transient hemodynamic instability that
may be induced by an intraoperative blood loss or surgi-
cal maneuvers such as aortic unclamping and major can-
cer resections.
Our experimental protocol promoted a predicted
hematocrit reduction to the desired target levels, while
Table 1 - Systemic oxygen delivery, consumption and extraction (DO2, VO2 and O2ER, respectively) and arterial pH, base
excess and lactate, in control (CT) moderate and severe hemodilution (MHD and SHD) groups
GROUPS BL HD0 HD30 HD60 HD120
Systemic DO2 CT 433± 26 442±32 398±43 414±49 318±30
MHD 535± 86 416±55a,b 384±63a,b 314±27a,b 304±32a,b
SHD 518±111 326±52a,b 271±22a,b 236±23a,b 202±30a,b
Systemic VO2 CT 75±11 80± 9 55± 3 73± 7 61± 9
MHD 68± 8 55±17 79±13 69±10 50±18
SHD 87±14 76±10 83± 6 70±10 78± 8
Systemic O2ER CT 18±3 18±2 15±1 18±2 20±3
MHD 14±2 14±5 21±4 23±4 20±7
SHD 19±4 27±4a,b,c 32±3 a,b,c 30±3 a,b,c 41±5 a,b,c
arterial pH CT 7.43±0.02 7.44±0.01 7.42±0.01 7.43±0.01 7.45±0.01
MHD 7.40±0.03 7.41±0.01 7.41±0.01 7.43±0.01 7.43±0.01
SHD 7.40±0.02 7.42±0.01 7.43±0.01 7.43±0.01 7.43±0.01
arterial BE CT 1.86±0.62 1.36±0.40 2.14±0.46 1.87±0.65 1.26±0.41
MHD 1.03±0.34 0.80±0.25 0.61±0.13 0.91±0.35 0.84±0.28
SHD 1.14±0.19 1.76±0.50 1.30±0.35 0.93±0.30 1.41±0.16
Systemic Lactate CT 1.2±0.1 1.1±0,1 1±0.2 0.8±0.2 0.9±0.2
MHD 1.3±0.4 1.1±0.3 1.3±0.2 1.1±0.3 1.1±0.3
SHD 1±0.3 0.5±0.2 0.7±0.2 0.8±0.2 0.8±0.3
Legends: (a) p<0.05 vs. CT; (b) p<0.05 vs. BL; (c) p<0.05 vs. MHD
Figure 3 – (A) Portal vein blood flow during the experiment in the control
(CT), moderate hemodilution (MHD), and severe hemodilution (SHD)
groups. (a) MHD vs CT, P < 0.05; (b) SHD vs CT, P < 0.05. (B) PCO2 gap
during the experiment in the control (CT), moderate hemodilution (MHD),
and severe hemodilution (SHD) groups. (d) SHD vs CT, P < 0.05; (c) MHD
vs SHD, P < 0.05; (b) SHD vs CT, P < 0.05.
Systemic and regional oxygen-derived variables, pH and
base excess, as well as lactate levels are depicted in Tables
1 and 2, respectively. Control animals showed no signifi-
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isovolemia was adequately maintained, as indicated by cen-
tral venous and pulmonary wedge pressures. With un-
changed cardiac filling pressures, arterial pressure was kept
stable due to an increase in cardiac output, largely related
to the reduction in systemic vascular resistance by the lower
viscosity. These compensatory hemodynamic changes are
expected.7 However, if a more severe anemia is induced,
impairment of myocardial oxygenation could jeopardize
cardiac performance.8 In this situation, the compensatory
increment of cardiac output may not occur and conse-
quently arterial pressure falls.
The mechanisms that increase cardiac output are also
responsible for the increased portal venous blood flow,
which was able to parallel cardiac output only because there
was no hypovolemia. This fact is important in terms of
blood flow distribution during normovolemic hemodilution.
In our experimental model, the critical oxygen deliv-
ery level to the various regional territories was probably
not achieved. While systemic oxygen consumption did not
vary significantly in the splanchnic region, it showed a
trend toward reduction, from 12 to 6 mL/kg/min. As ex-
tensively demonstrated, oxygen consumption decreases
whenever critical oxygen delivery levels are not achieved.9
However, systemic and portal vein lactate levels were kept
below 2 mmol/L, suggesting that anaerobic metabolism was
not present. Lactate levels only increase when anaerobic
metabolism is the main source of cellular energy and/or
when there is an impairment of lactate clearance.10 As the
portal vein blood flow was normal or even increased, lac-
tate clearance was maintained and, as already mentioned,
the level of hemoglobin was not sufficient to trigger anaero-
bic metabolism. Indeed, the level of venous oxygen satu-
ration was higher than those related to critical oxygen de-
livery in models of normovolemic hemodilution.11,12 By the
end of the experiment, the oxygen extraction rate was
around 40% (or oxygen venous saturation around 60%) in
severe hemodilution. In a model of decreased cardiac out-
put, the mean oxygen venous saturation that corresponded
to the critical point in which VO2 becomes dependent on
DO2 was around 25%.13 Hence, hemoglobin levels of about
5 mg/dL are still tolerated without evidence of anaerobic
metabolism.11
Hypoperfusion of the splanchnic vascular bed has been
implicated as the trigger of systemic inflammatory response
and multiple organ dysfunction syndrome, which com-
monly compromise the outcome after trauma or extensive
surgeries.14,15 A decrease in splanchnic DO2 caused by
hemodilution could amplify the harmful consequences of
tissue perfusion heterogeneity during complex surgeries.
The balance between oxygen delivery and consumption in
the splanchnic area could be assessed by the arterial and
portal oxygen saturation gradients, as well as by the por-
tal lactate levels. Alternatively, the portal-arterial pCO2 gra-
dient could be a surrogate marker of splanchnic blood flow
and/or perfusion.16,17 As the portal blood flow was main-
tained throughout the experiment, the splanchnic oxygen
delivery decreased exclusively because hemoglobin
dropped. However, as we have observed in the systemic
oxygen-derived variables, these hemoglobin levels were not
low enough to induce anaerobic metabolism. Additional
support for this evidence is the fact that splanchnic oxy-
gen consumption was maintained and portal lactate levels
did not increase.
In contrast, the behavior of the gastric mucosal-arterial
PCO2 gradient was different. Indeed, the PCO2 gap did not
increase significantly during the moderate isovolemic
Table 2 - Splanchnic oxygen delivery, consumption and extraction (DO2, VO2 and O2ER, respectively) and portal vein
lactate levels, in control (CT) moderate and severe hemodilution (MHD and SHD) groups.
GROUPS BL HD0 HD30 HD60 HD120
Splanchnic DO2 CT 82±9.0 83±11.3 78±9.4 75±7.5 66±4.6
MHD 62±9.3 51±9.6a,b 54±7.3a,b 50±6.6a,b 48±6.6a,b
SHD 84±17.9 41±6.8a,b 40±5.6a,b,c 38±4.5a,b,c 32±4.9a,b,c
Splanchnic VO2 CT 8±1 9±1 6±1 8±1 10±1
MHD 10±3 6±2 5±2 11±3 8±1
SHD 12±3 6±2 6±2 7±1 6±1
Splanchnic O2ER CT 10±2 11±2 9±1 11±1 16±2
MHD 16±3 17±7 11±4 22±5 19±5
SHD 16±4 16±5 16±4 20±3 22±5
Portal vein Lactate CT 1.3±0.1 1.2±0.1 0.8±0.2 1±0.1 1.1±0.2
MHD 1.4±0.4 1.1±0.3 1.4±0.3 1.4±0.3 1.2±0.3
SHD 1.1±0.3 0.7±0.3 0.8±0.3 0.8±0.2 0.9±0.3
Legends: (a) p<0.05 vs. CT; (b) p<0.05 vs. BL; (c) p<0.05 vs. MHD
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hemodilution, but did during severe isovolemic
hemodilution. Additionally, after HD30, all subsequent time
points showed significant increases in comparison to base-
line. This alteration in the SHD group was not paralleled
by splanchnic DO2, VO2, nor by portal vein blood flow, or
by portal lactate levels. There are some explanations for
this finding. Tissue PCO2 is linearly related to tissue blood
flow over a large range of flows, especially if hematocrit
remains stable. When tissue blood flow decreases, tissue
PCO2 increases simply because the CO2 removal rate de-
creases, particularly during aerobic metabolism.18,19 How-
ever, if tissue blood flow is kept normal, or even if it is
increased, tissue CO2 removal can be affected by the
hemoglobin level. For the same blood flow, but in the pres-
ence of a lower tissue hematocrit, CO2 removal can de-
crease. This is the first explanation for the greater PCO2
gap observed in the present experiment. Secondly, severe
isovolemic hemodilution may have induced anaerobic me-
tabolism at the mucosal layer. Although portal lactate lev-
els have not increased, this fact does not rule out the par-
ticipation of anaerobic tissue CO2 production. In fact, there
is no relationship between splanchnic metabolism and mu-
cosal perfusion.20 Even when the gastric mucosal perfusion
is severely compromised, portal vein lactate levels could
be normal, basically because the other tissues (muscular
and/or serosa) could maintain aerobic metabolism. How-
ever, when tissue DO2 falls below the critical point, there
is a decrease in CO2 production by aerobic tissue, which
counterbalances the anaerobically generated CO2. From our
data, it is not possible to exclude the anaerobic CO2 gen-
eration, since we did not measure mucosal PO2. However,
it has been shown that the main component of the PCO2
gap is flow, since in models of hypoxic hypoxia, the PCO2
gap is normal.21
Dubin et al performed a similar analysis in a sheep
model of isovolemic hemodilution or hemorrhage.22 They
induced a more severe isovolemic hemodilution, down to
a 5% hematocrit. At this point, the PCO2 gap reached circa
15 mm Hg. As the authors compared this PCO2 gap with a
40 mm Hg PCO2 gap after hemorrhage, thereby reducing
blood flows, they concluded that severe isovolemic
hemodilution is unable to reflect intestinal dysoxia. These
results are in agreement with ours. Although we did not
induce such an extreme decrease in hematocrit (15% vs.
5%), both models resulted in increased tissue PCO2, sug-
gesting that low hemoglobin levels do not induce tissue
dysoxia, but even though there microvascular derangement
is serious enough to impair tissue CO2 clearance. In a clini-
cal scenario, there are studies showing that a PCO2 gap
greater 15 mm Hg is an early marker of poor prognosis.23,24
In a model of shock and resuscitation, Diebel et al have
shown that there is no substantial increase in mucosal PCO2
when a 18% hematocrit was induced after volume resusci-
tation.25 Although these data apparently are in disagreement
to ours, we have noted that it is quite difficult to establish
the exact point at which tissue CO2 removal becomes im-
paired. Different experimental models and resuscitation
protocols do interfere with the relationship between flow
and hemoglobin. The combination of these factors will
probably determine the point at which tissue CO2 accumu-
lation begins. We believe that a direct comparison between
these studies is difficult to accomplish due to marked dif-
ferences between models, ie, normal versus hemorrhaged
animals.
Care must be exercised in extrapolating our results to
clinical practice. We used normal dogs submitted to a
laparotomy and splenectomy and placement of flow probes
and catheters. Our follow-up was very short. A long-term
study performed in unanesthetized baboons evaluated the
effects of withholding transfusion or lowering the transfu-
sion trigger to a hematocrit of 15%, similar to our severe
hemodilution model.26 These baboons adapted well to se-
vere anemia, and no adverse effects on long-term survival
occurred. We believe that their findings are in agreement
to ours, since they used normal baboons submitted to a sur-
gical stress (laparotomy)26 which was similar to that in our
dogs. In our acute model, we observed systemic and re-
gional hemodynamic stability, as well as the maintenance
of the metabolic status. Only gastric perfusion was mod-
erately affected. We consider this fact our major contribu-
tion. We expect that, under a greater surgical stress or
trauma, a more significant compromise of splanchnic
perfusion may occur in our model as well as in the baboon
model.
In spite of these limitations, we believe that our find-
ings may be clinically relevant. Restrictive transfusion poli-
cies have been widely recommended to avoid transfusion-
related reactions and immunoparalysis.27 Isovolemic
hemodilution may be used as a blood-saving technique for
several procedures, usually those not commonly associated
with hemodynamic instability, such as orthopedic surger-
ies. Vascular surgeries could be an ideal scenario for
isovolemic hemodilution. However, major vascular proce-
dures are associated with abrupt hemodynamic changes and
ischemia-reperfusion of large territories. In this scenario,
isovolemic hemodilution has been associated with greater
hemodynamic instability only during reperfusion.2
In summary, while moderate and severe normovolemic
hemodilution are associated with systemic and regional sta-
bility, intestinal mucosal hypercarbia was detected after se-
vere normovolemic hemodilution, suggesting impairment of
tissue CO2 removal. However, it is unclear from this present
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experiment whether this phenomenon may be also associated
with tissue oxygen compromise that could lead to cellular de-
rangement. Additionally, systemic and splanchnic
hemodynamic parameters and biochemical markers of anaero-
bic metabolism did not reflect the adequacy of gastric mu-
cosal perfusion. These data reinforce the need to monitor re-
gional tissue perfusion in settings of severe hemodilution when
larger surgical proceedings are performed.
RESUMO
Perin D, Cruz Jr. RJ, Silva E, Rocha-e-Silva M, Poli-de-
Figueiredo LF. Hematócrito baixo compromete a remoção
de CO2 da mucosa gástrica na hemodiluição normovolêmica
intensa experimental. CLINICS. 2006(5):445-52.
OBJETIVO: Os efeitos da hemodiluição normovolêmica
com diferentes níveis de hemoglobina na perfusão
esplâncnica são pouco conhecidos. Testamos a hipótese que
durante a hemodiluição moderada e acentuada, os
parâmetros hemodinâmicos sistêmicos e regionais e as va-
riáveis relacionadas ao metabolismo de oxigênio não re-
fletem a adequação da perfusão da mucosa gástrica.
MÉTODOS: Vinte e um cães anestesiados com fentanil e
vecurônio (16±1 kg) foram randomizados como controles
(CT, n=7, sem hemodiluição normovolêmica), hemo-
diluição normovolêmica moderada (Ht 25±3%, n=7) ou
hemodiluição normovolêmica acentuada (Ht 15±3%, n=7),
pela troca isovolêmica entre o sangue total e hidroxietil
amido a 6%, 20 mL/min até o hematócrito pré-estabeleci-
do para cada grupo. Os animais foram acompanhados por
120 min após a hemodiluição normovolêmica. Durante todo
o experimento foram medidos o débito cardíaco (CO, L/
min), o fluxo de veia porta (PVF, mL/min), e os gradien-
tes de CO2 veia porta-arterial e mucosa gástrica-arterial
(PV-artCO2 and PCO2-gap, mmHg, respectivamente).
RESULTADOS: O volume de sangue trocado foi de
33,9±3,3 mL/kg para hemodiluição normovolêmica mode-
rada e de 61,5±5,8 mL/kg para a hemodiluição
normovolêmica acentuada. A pressão arterial e os níveis de
lactato sistêmico e regional permaneceram estáveis em to-
dos os grupos. Houve aumentos iniciais de débito cardíaco
e de fluxo de veia porta, tanto na hemodiluição
normovolêmica moderada quanto na hemodiluição
normovolêmica acentuada; o consumo de oxigênio sistêmico
e regional permaneceram estáveis, principalmente por con-
ta de aumentos na taxa de extração de oxigênio. O PCO2-
gap apresentou aumento significativo apenas nos animais
submetidos a hemodiluição normovolêmica acentuada.
CONCLUSÃO: Ocorre estabilidade hemodinâmica global
e regional tanto na hemodiluição normovolêmica modera-
da quanto na acentuada. Entretanto, o hematócrito de 15%
induziu acidose moderada de mucosa gástrica, o que pode
ser relevante em procedimentos cirúrgicos de grande porte
ou no trauma.
UNITERMOS: Hemodiluição. Hemodinâmica regional.
Metabolismo do oxigênio. Perfusão esplâncnica.
Tonometria a gás.
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